US 11266746
Therapeutic antitumor combination of a TLR4 ligand with other treatments
granted A61KA61K31/4745A61K31/664
Quick answer
US patent 11266746 (Therapeutic antitumor combination of a TLR4 ligand with other treatments) held by The United Slates of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United Slates of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4745, A61K31/664, A61K38/1709, A61K39/39558